
The Eye-Tracking Boom Is Coming – But You’ll Miss It If You Blink
There was a time—around January 2020—when investing in a little-known biotech stock called Moderna seemed like a gamble. Months later, it was the hottest ticket on Earth. The reason? A sudden, global event thrust one niche technology into mainstream necessity. Now ask yourself: what’s the next Moderna? I’m not saying it is eye tracking—but I’m […]